Source: Biospectrum Asia

SYNthesis: Viva Biotech accelerates development of innovative drug R & D services

Enters a Strategic Acquisition Agreement with SYNthesis

Read full article »
SYNthesis's Competitors | SYNthesis's News | SYNthesis's Financials
Stay up-to-date with the latest news on SYNthesis
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Xianyong Bu's photo - Managing Director of SYNthesis

Managing Director

Xianyong Bu

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on SYNthesis